DEF 14A: Focus Impact BH3 Acquisition Seeks Extension to Complete Business Combination with XCF Global Capital
Proxy Statement
Focus Impact BH3 Acquisition Company is seeking stockholder approval to extend the deadline for completing its business combination with XCF Global Capital from July 31, 2024, to February 7, 2025, with potential further monthly extensions.
Summary
- Focus Impact BH3 Acquisition Company (BHAC) is seeking stockholder approval for an extension to complete its business combination with XCF Global Capital.
- A special meeting is scheduled for July 23, 2024, to vote on proposals to extend the deadline for completing the business combination from July 31, 2024, to February 7, 2025, and potentially up to April 7, 2025, with monthly extensions.
- The company is also seeking to remove a limitation on redemptions that requires BHAC to maintain at least $5,000,001 in net tangible assets.
- If the extension is not approved, BHAC will liquidate, and public stockholders will receive a pro-rata share of the trust account, estimated at $10.89 per share as of June 28, 2024.
- The Sponsor and other insiders have agreed to vote in favor of the extension and waive their redemption rights on certain shares.
- The amount remaining in the Trust Account may be significantly less than the approximately $25,186,284 that was in the Trust Account as of June 28, 2024 (including interest not previously released to BHAC to pay its taxes).
Sentiment
Score: 4
Explanation: The document is mostly neutral, but the need for an extension and the potential for liquidation introduce negative sentiment. The high redemption rate also suggests investor concern.
Positives
- The extension provides BHAC with additional time to complete the business combination with XCF Global Capital.
- Approval of the Redemption Limitation Amendment Proposal would allow BHAC to proceed with the Charter Extension even if redemptions reduce net tangible assets below $5,000,001.
- Stockholders have the right to redeem their shares for cash regardless of their vote on the extension.
- The Sponsor and insiders are aligned with stockholders, voting in favor of the extension and waiving redemption rights on certain shares.
Negatives
- If the extension is not approved, BHAC will liquidate, and stockholders will receive a pro-rata share of the trust account, potentially foregoing future gains from the business combination.
- Redemptions could significantly reduce the cash available in the trust account, potentially impacting the combined company's ability to execute its business plan.
- There is no guarantee that the business combination will be completed even if the extension is approved.
- The Sponsor and insiders have interests that may differ from those of public stockholders.
Risks
- The ability of public stockholders to exercise redemption rights may adversely affect the liquidity and trading of BHAC's securities and may impact its ability to complete the Business Combination.
- BHAC may be subject to suspension and delisting from Nasdaq if it does not complete a business combination by October 7, 2024.
- A 1% U.S. federal excise tax could be imposed on BHAC in connection with redemptions by BHAC of its shares.
- Changes to laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect BHAC's business, including its ability to negotiate and complete its initial business combination.
- If BHAC is deemed to be an investment company under the Investment Company Act, it may be required to institute burdensome compliance requirements and its activities may be restricted, which may make it difficult for BHAC to complete its business combination.
Future Outlook
BHAC intends to continue pursuing the business combination with XCF Global Capital if the extension is approved. If the extension is not approved, BHAC will liquidate.
Management Comments
- BHAC's Board has determined that it is in the best interests of BHAC to seek an extension of the Original Termination Date and have BHAC's stockholders approve the Extension Amendment Proposal to allow for a period of additional time to consummate the Business Combination.
- The Board believes it is in the best interests of BHAC and its stockholders for BHAC to be allowed to effect redemptions irrespective of the Redemption Limitation.
Industry Context
SPACs often seek extensions to complete business combinations due to market conditions or difficulties in finding suitable targets. The proposed amendments reflect the challenges faced by SPACs in the current environment.
Comparison to Industry Standards
- Many SPACs, such as FIAC, are facing similar challenges in completing business combinations within the initial timeframe.
- The redemption rate of 89.9% of the shares of Class A Common Stock that were initially issued in the Initial Public Offering is high compared to other SPACs seeking extensions, indicating a lack of investor confidence.
- The proposed amendments to the charter are similar to those sought by other SPACs facing deadlines to complete business combinations.
Stakeholder Impact
- Stockholders will have the opportunity to vote on the extension and redeem their shares.
- Employees of BHAC and XCF Global Capital face uncertainty regarding the future of the business combination.
- Creditors and suppliers of BHAC may be impacted by the potential liquidation.
Next Steps
- Stockholders will vote on the extension and redemption limitation amendment proposals at the special meeting on July 23, 2024.
- If the extension is approved, BHAC will continue to pursue the business combination with XCF Global Capital.
- If the extension is not approved, BHAC will liquidate.
Key Dates
| Date | Description |
|---|---|
| February 23, 2021 | Original certificate of incorporation of the Corporation was filed with the Secretary of State of the State of Delaware |
| October 7, 2021 | BHAC consummated its Initial Public Offering |
| December 7, 2022 | BHAC effected a charter amendment and a trust amendment, the effect of which was to change its termination date from April 7, 2023 to August 7, 2023 |
| September 27, 2023 | BHAC, the Former Sponsor and the Sponsor entered into a Purchase Agreement |
| October 6, 2023 | BHAC effected a second charter amendment, the effect of which was to change its termination date to July 31, 2024 |
| November 2, 2023 | The Purchase Agreement closed effective |
| March 12, 2024 | BHAC, NewCo, Merger Sub 1, Merger Sub 2 and XCF, entered into the Business Combination Agreement |
| June 20, 2024 | Record date for determining BHAC's stockholders entitled to receive notice of and vote at the Stockholder Meeting |
| June 28, 2024 | Most recent practicable date prior to the date of the accompanying proxy statement |
| July 1, 2024 | Date of the proxy statement |
| July 19, 2024 | Redemption Deadline |
| July 23, 2024 | Special meeting of stockholders to be held |
| July 31, 2024 | Original Termination Date |
| February 7, 2025 | Charter Extension Date |
| April 7, 2025 | Latest possible Termination Date after monthly extensions |
Keywords
business combination, extension amendment, redemption limitation, special meeting, XCF Global Capital, Focus Impact BH3 Acquisition, BHAC, liquidation, redemption, sponsor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.